These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23747596)

  • 1. Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
    Honma S; Takahashi N; Shinohara M; Nakamura K; Mitazaki S; Abe S; Yoshida M
    Eur J Pharmacol; 2013 Sep; 715(1-3):181-8. PubMed ID: 23747596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclooxygenase (COX)-2 inhibition on mouse renal interstitial fibrosis.
    Honma S; Shinohara M; Takahashi N; Nakamura K; Hamano S; Mitazaki S; Abe S; Yoshida M
    Eur J Pharmacol; 2014 Oct; 740():578-83. PubMed ID: 24975097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs ameliorate opposite enzymatic changes in ileal 5-hydroxytryptamine metabolism in the delayed phase after cisplatin administration to rats.
    Ju C; Hamaue N; Machida T; Liu Y; Iizuka K; Wang Y; Minami M; Hirafuji M
    Eur J Pharmacol; 2008 Jul; 589(1-3):281-7. PubMed ID: 18534574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of meloxicam on aluminum overload-induced cerebral damage in mice.
    Jun-Qing Y; Bei-Zhong L; Bai-Cheng H; Qi-Qin Z
    Eur J Pharmacol; 2006 Oct; 547(1-3):52-8. PubMed ID: 16928369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.
    Oba M; Miwa K; Fujimura T; Harada S; Sasaki S; Oyama K; Ohta T; Hattori T
    Cancer; 2009 Jan; 115(2):454-64. PubMed ID: 19110997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism and effect of cyclooxygenase-2 inhibitor meloxicam on the protection of diabetic nephropathy in rats].
    Liu ZC; Zhou QL; Ouyang C; Deng SL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):635-8. PubMed ID: 16114545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eupafolin inhibits PGE2 production and COX2 expression in LPS-stimulated human dermal fibroblasts by blocking JNK/AP-1 and Nox2/p47(phox) pathway.
    Tsai MH; Lin ZC; Liang CJ; Yen FL; Chiang YC; Lee CW
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):240-51. PubMed ID: 24967690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation.
    Cruz R; Quintana-Hau JD; González JR; Tornero-Montaño R; Baiza-Durán LM; Vega L
    Br J Ophthalmol; 2008 Jan; 92(1):120-5. PubMed ID: 17962388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
    Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
    Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling.
    Potočnjak I; Škoda M; Pernjak-Pugel E; Peršić MP; Domitrović R
    Mol Nutr Food Res; 2016 Mar; 60(3):530-41. PubMed ID: 26603374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
    Stichtenoth DO; Wagner B; Frölich JC
    J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.
    Martin AI; Nieto-Bona MP; Castillero E; Fernandez-Galaz C; Lopez-Menduina M; Gomez-Sanmiguel AB; Gomez-Moreira C; Villanua MA; Lopez-Calderon A
    J Physiol Pharmacol; 2012 Dec; 63(6):649-59. PubMed ID: 23388481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam, a COX-2 inhibitor, ameliorates ischemia/reperfusion injury in non-heart-beating donor livers.
    Stoffels B; Yonezawa K; Yamamoto Y; Schäfer N; Overhaus M; Klinge U; Kalff JC; Minor T; Tolba RH
    Eur Surg Res; 2011; 47(3):109-17. PubMed ID: 21757922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of cisplatin-induced rat renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
    Yamamato E; Izawa T; Sawamoto O; Juniantito V; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2012 Sep; 64(6):625-31. PubMed ID: 21256724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
    Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
    Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice.
    Hofer M; Pospíšil M; Dušek L; Hoferová Z; Weiterová L
    Radiat Res; 2011 Aug; 176(2):269-72. PubMed ID: 21663397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
    Granado M; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.